News | July 15, 2025
Merck launches AAW workstation to advance lab automation
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
New platform powered by Opentrons expands lab automation to accelerate scientific discovery
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Capricor’s BLA for Deramiocel received Priority Review in March 2025
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Surpassing 1,000 Company Owned Company Operated stores
A triple-action Formula for comprehensive respiratory relief
Extended lab space for product development, customer demos, and training
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
Eylea 8 mg is the first and only anti-vascular endothelial growth factor (VEGF) treatment in the EU with treatment intervals of up to 6 months for both patients with nAMD and DME
The proceeds from the QIP will be utiized for purchase of outstanding optionally convertible debentures
Subscribe To Our Newsletter & Stay Updated
